what is going on with semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Semaglutide 3-Month Program now Available

Namiki, T

Polymorphic Light Eruption (PLE) Mitigation: MT-I has been reported to minimize the severity of rashes in PLE patients when administered as 16mg implants over a 4-month duration, per a 2010 phase-3 trial [19]

An earlier double-blind RCT by Arjinpathana and Asawanonda published in the Journal of Dermatological Treatment in 2012 (n=60, oral GSH 500 mg/day for 4 weeks) found that oral glutathione produced a modest skin-lightening effect in sun-exposed areas versus placebo, establishing the foundational clinical signal for the oral route

The body needs it

Rev Environ Contam Toxicol 229:118

The CNS immune landscape from the viewpoint of a T cell